Table 2.
Effects of Different Components of Honey in Various Neurological Disorders.
Disease | Component | Effect | References |
---|---|---|---|
Alzheimer’s Disease | Quercetin | Improves mitochondrial activity | [89] |
Activates Nrf-2 signaling | [90] | ||
Deceases oxidative stress | |||
Reduces oxidative stress via PON2 activity | [91] | ||
Reduces neuroinflammation | [92,93] | ||
Decreases astrogliosis | |||
Prevents neurodegeneration | |||
Recovers cognitive disabilities | |||
Myricetin | Improves memory and cognitive function | [94] | |
Prevents the formation of fibrils as well as oligomers of Aβ | [95] | ||
Anti-tau protein effect | |||
↓ Acetylcholinesterase | [96] | ||
↑ Acetylcholine | |||
Exhibits anti-inflammatory activity | [97,98] | ||
Inhibition of the NF-κB pathway and NLRP3 inflammasome | |||
Prevents the formation of fibrils as well as oligomers of Aβ | [99] | ||
Kaempferol | Decreases lipid peroxidation and senile plaque formation | [100] | |
Protects from apoptotic damage | |||
Regulates concentrations of antioxidative enzymes | [101] | ||
↓ TNF-α and inhibits inflammation | |||
Exhibits anti-apoptotic activity | [102] | ||
Downregulates Bcl-2-associated X protein (Bax) and cleaved caspase-9 | |||
Increases neuronal density in the hippocampus | [103] | ||
Downregulates inflammatory proteins | [104] | ||
Protects from oxidative damage | [105] | ||
Luteolin | Alleviates oxidative stress | [106] | |
Scavenges free radicals | |||
Downregulates inflammatory and apoptotic proteins | |||
Improves memory deficits | [107] | ||
Maintains neuronal density | |||
Galangin | Diminishes autophagy | [108] | |
Decreases levels of p-tau, β-secretase, and Aβ42 | |||
↑ Acetylcholine | [109] | ||
Improves cognitive functions | |||
Caffeic acid | ↓ Acetylcholinesterase | [110] | |
↓ Inflammation | |||
↓ Oxidative stress | |||
Cinnamic acid | Attenuates the formation of amyloid plaques | [111] | |
Activates PPARα | |||
Improves memory functions | |||
Parkinson’s Disease | Quercetin | Protects from degeneration | [112] |
↑ Dopamine levels | |||
↑ Brain-Derived Neurotrophic Factor expression | |||
↑ Energy production of mitochondria | |||
Restores activities of antioxidant enzymes | [113] | ||
Repairs cognitive deficits | |||
↓ Endoplasmic reticulum stress | [114] | ||
↓ C/EBP homologous protein (CHOP) | |||
↑ Autophagy | |||
↑ Beclin-1 expression | |||
Myricetin | ↓ Degeneration | [115] | |
↑ Dopamine levels | |||
Inhibits inflammation | [116] | ||
Prevents the activation of microglia | |||
↓ Expression of inflammatory cytokines | |||
Chrysin | ↑ Expression of a survival factor MEF2D | [117] | |
Inhibits MAO-B | |||
Alleviates oxidative stress | [118] | ||
Prevents inflammation and dysfunction of Na+, K+-ATPase pump | |||
Ameliorates neuronal loss | [119] | ||
Improves memory | |||
Ellagic acid | Inhibits MAO activity | [120] | |
Prevents the loss of neurons | |||
↓ Oxidative stress | |||
Modulates levels of antioxidant enzymes | [121] | ||
Protects from oxidative insult | |||
Diminishes apoptosis | [122] | ||
Inhibits MAO-B | |||
Modulates ERβ/Nrf2/HO-1 signaling cascade | |||
Cinnamic acid | Protects neurodegeneration | [123] | |
Activates Peroxisome Proliferator Activating Receptor α (PPARα) | |||
Galangin | Inhibits microglial activation | [124] | |
Suppresses inflammatory factors | |||
Activates PPAR-γ | [125,126,127] | ||
Inhibits inflammation | |||
Prevents apoptosis | |||
Protects from oxidative damage | |||
Apigenin | Exhibits antioxidative function | [128] | |
Inhibits MAO | |||
Prevents apoptosis | |||
Inhibits caspase-3 activation | |||
Huntington’s Disease | Quercetin | Improves motor functions | [129] |
Regulates peroxisome proliferator-activated receptor gamma, coactivator (PGC-1), or sirtuins (SIRT1) | |||
↑ Energy production of mitochondria | |||
Ameliorates behavioral malfunctions | [130] | ||
Exhibits anxiolytic effect | |||
Myricetin | Reduces aggregation of polyglutamine | [131] | |
↓ Proteo toxicity | [132] | ||
Repairs behavioral changes | |||
Chrysin | Upregulates anti-apoptotic factor | [133] | |
Downregulates pro-apoptotic factor | |||
Restores neurobehavioral functions | [134] | ||
↑ Serotonin | |||
Chlorogenic acid | Protects from genotoxicity | [135] | |
Amyotrophic Lateral Sclerosis | Quercetin | Inhibits aggregation of Cu-Zn superoxide dismutase (SOD) | [136,137] |
Kaempferol | Prevents cell death | [138,139] | |
Reduces aggregation of superoxide dismutase 1 (SOD1) | |||
↑ AMPK phosphorylation | |||
Inhibits mTOR phosphorylation | |||
Boosts up autophagy | |||
Coumaric acid | Ameliorates oxidative stress and endoplasmic reticulum stress | [140] | |
↑ Autophagy | |||
Gallic acid | ↑ Levels of antioxidant enzymes | [141] | |
↓ Lipid peroxidation | |||
Downregulates inflammatory cytokines such as TNF-α, IL-6, IL-β, and NF-κB | |||
Improves motor functions | |||
Prevents glutamate excitotoxicity | [142] | ||
Inhibits the formation of neurofibrillary tangles | |||
Improves motor skills | |||
↓ TDP-43 proteotoxicity | [143] | ||
Attenuates seizures | |||
Epilepsy | Quercetin | Inhibits activation of microglial cells and inflammatory cytokines | [144] |
Attenuates neurodegeneration | |||
Inhibits expression of the gene for GABA receptors | [145] | ||
Reduces depression | |||
Restores tryptophan levels | [146] | ||
Exerts anticonvulsant effect | |||
Modulates Glycinergic and GABAergic ion channels | [147] | ||
Reduces behavioral signs of seizures | |||
↓ Neuronal loss | [148] | ||
↓ Astrocyte activation | |||
Myricetin | Ameliorates intensity of seizures | [149,150] | |
Inhibits apoptosis | |||
Downregulates Bad, Bax, and cleaved caspase 3 | |||
Upregulates Bcl-2 and Bcl-xL | |||
Normalizes glutamate/GABA | |||
Luteolin | Improves cognitive deficits | [151] | |
↑ Expression of Brain-Derived Neurotrophic Factor (BDNF) | |||
Exhibits anticonvulsant effect | [152] | ||
↑ Activation of receptors for GABAA | |||
Reduces oxidative stress | |||
Improves cognition impairments | [153] | ||
Modulates CaM-CaMPK signaling pathway | |||
Attenuates seizures | |||
Chrysin | Modulates GABAA receptors | [154] | |
Abrogates convulsion-induced oxidative damage | |||
↓ The severity of epileptic seizures | [155] | ||
↓ Apoptosis | |||
Boosts the expression of Nrf2, NQO-1, and HO-1 | |||
Apigenin | Reduces neuronal loss | [156] | |
↓ Release of cytochrome c from mitochondria | |||
Alleviates apoptosis | |||
Inhibits overexpression of hypochlorite (HClO) | [157,158] | ||
↓ Oxidative damage | |||
Averts cognitive impairments | [159] | ||
Exerts antidepressant and anti-anxiolytic effects | |||
↑ Expression of Brain-Derived Neurotrophic Factor (BDNF) | |||
Ferulic acid | Palliates depression | [160] | |
↓ Levels of proinflammatory cytokines such as TNF-α and IL-1β | |||
Inhibits Cyclooxygenase 2 (COX2) activity | |||
Modulates corticosterone levels | |||
Ameliorates oxidative stress | [161] | ||
Upregulates neuroprotective Heat shock protein 70 (Hsp70) and neurotransmitters such as Serotonin (5-HT) and norepinephrine | |||
Diminishes oxidative stress | [162] | ||
Repairs cognitive deficits and seizure activity | |||
Improves memory functions and learning capacities | [163] | ||
Inhibits apoptotic process | |||
Scavenges free radicles | |||
Naringenin | ↑ Antioxidant enzymes | [164] | |
Restores neuronal morphology | |||
↓ Neurodegeneration | |||
Impedes occurrence of seizures | [165] | ||
↓ Granule cell disruption (GCD) in the hippocampus | |||
Ameliorates generation of proinflammatory cytokines | |||
Exerts anticonvulsant effect | [166] | ||
Agonist effect on GABAA receptors | |||
↓ Glutamate transmission | |||
Schizophrenia | Quercetin | Scavenges free radicals | [167] |
↑ Levels of antioxidant enzymes | |||
Reduces depressive behaviors | [168] | ||
Improves behavioral impairments | [169] | ||
Boosts up antipsychotic therapy | [170] | ||
Depression | Quercetin | ↑ Levels of antioxidant enzymes | [171,172] |
↓ Decrease levels of inflammatory cytokines | |||
Accrues serotonin level | |||
Mitigates depressive behaviors | [173] | ||
Modulates levels of BDNF | |||
Myricetin | Recovers hopeless behaviors | [174,175] | |
Regulates BDNF levels | |||
Exerts antioxidant effect | |||
Kaempferol | Exert anti-depressive effects | [176] | |
↑ Levels of antioxidant enzymes | |||
Upregulates AKT/β-catenin cascade | |||
Chrysin | Upregulates nerve growth factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) | [177] | |
Normalizes Na+, K+-ATPase activity | |||
Employs anti-depressant effects | [178] | ||
Inhibits kynurenine pathway | |||
Elevates the levels of serotonin (5HT) | |||
Naringenin | Performs anti-depressive activity | [179] | |
Restores antioxidant enzymes’ levels | |||
Modulates serotonin levels | |||
Downregulates inflammation mediators | |||
Inhibits acetylcholinesterase activity | [180] | ||
Mitigates oxidative damage | |||
Upregulates BDNF, Sonic Hedgehog (Shh) signaling, NKX2.2, and PAX6 | [181] | ||
Coumaric acid | Improves behavioral hopelessness | [182] | |
Lessens inflammation-associated alterations | |||
Enhances neurotrophic activity | |||
Ferulic acid | Abrogates depression-like behaviors | [183] | |
Downregulates pro-inflammatory cytokines | |||
Downregulates factors associated with inflammation and apoptosis | [184] | ||
Mitigates depression |